Fig. 5From: Secreting-lux/pT-ClyA engineered bacteria suppresses tumor growth via interleukin-1β in two pathwaysSerum IL-1β levels in different groups at different time points. a Serum IL-1β levels were measured by ELISA. Results showed that serum IL-1β levels were significantly higher in mice treated with engineered secreting-lux/pT-ClyA salmonella compared to other groups. b Serum IL-1β levels in PBS, SL, S.t-ΔpGlux/pT-ClyA(+) at indicated timesBack to article page